REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Wellnanopharm Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Wellnanopharm Sp. z o.o. Profile Updated: November 18, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Wellnanopharm Sp. z o.o. is based in Poland, with the head office in Krakow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on March 08, 2019. The company’s latest financial report indicates a net sales revenue drop of 81.97% in 2022. Its’ total assets recorded a growth of 238.96%. In 2022, Wellnanopharm Sp. z o.o.’s net profit margin decreased by 22980.48%.

Headquarters
Ul. Jerzego Samuela Bandtkiego 19
Krakow; Malopolskie; Postal Code: 30-129

Contact Details: Purchase the Wellnanopharm Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Wellnanopharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Wellnanopharm Sp. z o.o. report to view the information.
Incorporation Date:
March 08, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
35%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Wellnanopharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-81.97%▼
Total operating revenue
-88.34%▼
Operating profit (EBIT)
36.66%▲
Net Profit (Loss) for the Period
41.09%▲
Total assets
238.96%▲
Total equity
-30.75%▼
Operating Profit Margin (ROS)
-23651.22%▼
Net Profit Margin
-22980.48%▼
Return on Equity (ROE)
-49.63%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo